课题基金 / 基金详情

Role of sex steroids in female TIEG-null mouse bone loss

Role of sex steroids in female TIEG-null mouse bone loss
性类固醇在雌性 TIEG 缺失小鼠骨质流失中的作用
批准号:
7109536
负责人:
John R. Hawse
金额:
$4.88万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-09-01 至 2007-08-31

项目摘要

项目成果

John R. Hawse的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): TGF-beta inducible early gene-1 (TIEG) is a member of the Kruppel-like transcription factor family originally cloned from human osteoblasts that is known to play an important role in transcriptional regulation and in TGF-beta mediated Smad signaling. TIEG is rapidly induced by estrogen in osteoblast cells and this induction seems to be specifically through the action of estrogen receptor-beta. Through the development and characterization of TIEG-null mice, we have shown that female animals display significantly weaker, smaller and less dense bones relative to wild-type litter mates. Intriguingly, these differences are not detectable in male animals implying a role for the sex steroids, in combination with the loss of TIEG expression, in the observed gender specific bone phenotype. Based on the above observations, it is the goal of this proposal to further characterize the molecular basis behind the gender specific bone phenotype, to identify the role of estrogen and/or testosterone in this gender specificity and to elucidate the mechanisms by which TIEG is specifically induced by estrogen receptor-beta.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ERβ repurposes EZH2 to suppress oncogenic NFκB signaling in TNBC
  • 批准号:
    10540349
  • 项目类别:
  • 资助金额:
    $50.63万
  • 财政年份:
    2021
  • 负责人:
    John R. Hawse
  • 依托单位:
ERβ repurposes EZH2 to suppress oncogenic NFκB signaling in TNBC
  • 批准号:
    10116790
  • 项目类别:
  • 资助金额:
    $47.69万
  • 财政年份:
    2021
  • 负责人:
    John R. Hawse
  • 依托单位:
ERβ repurposes EZH2 to suppress oncogenic NFκB signaling in TNBC
  • 批准号:
    10320463
  • 项目类别:
  • 资助金额:
    $49.96万
  • 财政年份:
    2021
  • 负责人:
    John R. Hawse
  • 依托单位:
Project 2: Therapeutic targeting of estrogen receptor beta in triple negative breast cancer
  • 批准号:
    10017908
  • 项目类别:
  • 资助金额:
    $28.3万
  • 财政年份:
    2005
  • 负责人:
    John R. Hawse
  • 依托单位:
海外基金